Covid-19 Research

Review Article

COVID-19 Vaccine Acceptability and Hesitancy in Africa: Implications for Addressing Vaccine Hesitancy

Journal of Biomedical Research & Environmental Sciences article abstract with citation details, DOI, publication dates, subject areas, full text links, and references.

View DOI Submit Manuscript

Article Details

Publication record, authors, dates, abstract, and full text access.

Open Access
Article Type Review Article
Subject Medicine Group
OCLC 9331581478
Steward Mudenda*
Issue: Volume2-Issue10
Pages: 999-1004
Received: 2021-10-21
Accepted: 2021-10-28
Published: 2021-10-29

Abstract

Background: Increased acceptance and uptake of Coronavirus Disease 2019 (COVID-19) vaccines is very essential in containing the ongoing COVID-19 pandemic. Vaccine hesitancy is a threat to public health containment of infectious diseases.

Aim: The main aim of this study was to review published articles regarding COVID-19 vaccine acceptability and hesitancy across all populations in Africa.
Materials and methods: This was a narrative review. A comprehensive literature search was done using PubMed, Google Scholar, Scopus, and EMBASE using the keywords vaccine acceptability, vaccine hesitancy, COVID-19 vaccine, COVID-19 pandemic, H1N1 vaccine, swine flu, swine flu vaccine, Africa, and the Boolean word AND. The cited literature was published between March 2001 and June 2021.

Results: The few studies were done in Africa so far are among healthcare workers and medical students. Acceptance of vaccination against COVID-19 in Africa ranged from 15.4% to 55.9%. This shows increased hesitancy to receive the COVID-19 vaccines in African countries. Many people were concerned about the potential adverse effects and ineffectiveness of COVID-19 vaccines. Misinformation about the COVID-19 vaccines has contributed to the hesitancy reported from different studies. Moreover, sociodemographic characteristics were also predictors of the acceptability of COVID-19 vaccines.

Conclusion: Low acceptability rates reported in Africa indicates increased hesitancy to vaccination against COVID-19. The low acceptance of vaccines in Africa can hinder the required 60-70% vaccinations to achieve herd immunity. Therefore, there is a need to develop strategies that will address hesitancy against the COVID-19 vaccines across countries and populations in Africa and the entire globe.

FullText HTML FullText PDF DOI: 10.37871/jbres1342 Crossmark

Certificate of Publication

Certificate of Publication

Copyright

© 2021 Mudenda S. Distributed under Creative Commons CC-BY 4.0 Creative CommonsAttribution

How to cite this article

Mudenda S. COVID-19 Vaccine Acceptability and Hesitancy in Africa: Implications for Addressing Vaccine Hesitancy. J Biomed Res Environ Sci. 2021 Oct 29; 2(10): 999-1004. doi: 10.37871/jbres1342, Article ID: JBRES1342, Available at: https://www.jelsciences.com/articles/jbres1342.pdf

Subject area(s)

Public Health

University/Institute

University of Zambia

References

  1. Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF. The proximal origin of SARS-CoV-2. Nat Med. 2020 Apr;26(4):450-452. doi: 10.1038/s41591-020-0820-9. PMID: 32284615; PMCID: PMC7095063.
  2. Liu YC, Kuo RL, Shih SR. COVID-19: The first documented coronavirus pandemic in history. Biomed J. 2020 Aug;43(4):328-333. doi: 10.1016/j.bj.2020.04.007. Epub 2020 May 5. PMID: 32387617; PMCID: PMC7199674.
  3. Sohrabi C, Alsafi Z, O'Neill N, Khan M, Kerwan A, Al-Jabir A, Iosifidis C, Agha R. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Int J Surg. 2020 Apr;76:71-76. doi: 10.1016/j.ijsu.2020.02.034. Epub 2020 Feb 26. Erratum in: Int J Surg. 2020 May;77:217. PMID: 32112977; PMCID: PMC7105032.
  4. Cucinotta D, Vanelli M. WHO Declares COVID-19 a Pandemic. Acta Biomed. 2020 Mar 19;91(1):157-160. doi: 10.23750/abm.v91i1.9397. PMID: 32191675; PMCID: PMC7569573.
  5. Chileshe M, Mulenga D, Mfune RL, Nyirenda TH, Mwanza J, Mukanga B, Mudenda S, Daka V. Increased number of brought-in-dead cases with COVID-19: is it due to poor health-seeking behaviour among the Zambian population? Pan Afr Med J. 2020 Oct 8;37:136. doi: 10.11604/pamj.2020.37.136.25967. PMID: 33425169; PMCID: PMC7757280.
  6. Zanke AA, Thenge RR, Adhao VS. COVID-19: A pandemic declare by world health organization. IP Int J Compr Adv Pharmacol. 2020;5(2):49-57. doi: 10.18231/j.ijcaap.2020.012
  7. Alwan NA, Burgess RA, Ashworth S, Beale R, Bhadelia N, Bogaert D, Dowd J, Eckerle I, Goldman LR, Greenhalgh T, Gurdasani D, Hamdy A, Hanage WP, Hodcroft EB, Hyde Z, Kellam P, Kelly-Irving M, Krammer F, Lipsitch M, McNally A, McKee M, Nouri A, Pimenta D, Priesemann V, Rutter H, Silver J, Sridhar D, Swanton C, Walensky RP, Yamey G, Ziauddeen H. Scientific consensus on the COVID-19 pandemic: we need to act now. Lancet. 2020 Oct 31;396(10260):e71-e72. doi: 10.1016/S0140-6736(20)32153-X. Epub 2020 Oct 15. Erratum in: Lancet. 2020 Oct 19;: PMID: 33069277; PMCID: PMC7557300.
  8. Kasanga M, Mudenda S, Gondwe T, Chileshe M, Solochi B, Wu J. Impact of COVID-19 on blood donation and transfusion services at Lusaka provincial blood transfusion centre, Zambia. Pan Afr Med J. 2020 Jun 10;35(Suppl 2):74. doi: 10.11604/pamj.supp.2020.35.2.23975. PMID: 33623598; PMCID: PMC7875808.
  9. Cao W, Chen C, Li M, Nie R, Lu Q, Song D, Li S, Yang T, Liu Y, Du B, Wang X. Important factors affecting COVID-19 transmission and fatality in metropolises. Public Health. 2021 Jan;190:e21-e23. doi: 10.1016/j.puhe.2020.11.008. Epub 2020 Nov 19. PMID: 33339626; PMCID: PMC7674010.
  10. Greyling T, Rossouw S, Adhikari T. The good, the bad and the ugly of lockdowns during Covid-19. PLoS One. 2021 Jan 22;16(1):e0245546. doi: 10.1371/journal.pone.0245546. PMID: 33481848; PMCID: PMC7822257.
  11. Atalan A. Is the lockdown important to prevent the COVID-9 pandemic? Effects on psychology, environment and economy-perspective. Ann Med Surg (Lond). 2020 Aug;56:38-42. doi: 10.1016/j.amsu.2020.06.010. Epub 2020 Jun 14. Erratum in: Ann Med Surg (Lond). 2020 Jul 09;56:217. PMID: 32562476; PMCID: PMC7293850.
  12. Girum T, Lentiro K, Geremew M, Migora B, Shewamare S. Global strategies and effectiveness for COVID-19 prevention through contact tracing, screening, quarantine, and isolation: a systematic review. Trop Med Health. 2020 Nov 23;48(1):91. doi: 10.1186/s41182-020-00285-w. PMID: 33292755; PMCID: PMC7680824.
  13. Chu DK, Akl EA, Duda S, Solo K, Yaacoub S, Schünemann HJ; COVID-19 Systematic Urgent Review Group Effort (SURGE) study authors. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis. Lancet. 2020 Jun 27;395(10242):1973-1987. doi: 10.1016/S0140-6736(20)31142-9. Epub 2020 Jun 1. PMID: 32497510; PMCID: PMC7263814.
  14. Krishan K, Kanchan T. Lockdown is an effective 'vaccine' against COVID-19: A message from India. J Infect Dev Ctries. 2020 Jun 30;14(6):545-546. doi: 10.3855/jidc.12931. PMID: 32683342.
  15. Güner R, Hasanoğlu I, Aktaş F. COVID-19: Prevention and control measures in community. Turk J Med Sci. 2020 Apr 21;50(SI-1):571-577. doi: 10.3906/sag-2004-146. PMID: 32293835; PMCID: PMC7195988.
  16. Lu S. Timely development of vaccines against SARS-CoV-2. Emerg Microbes Infect. 2020 Mar 8;9(1):542-544. doi: 10.1080/22221751.2020.1737580. PMID: 32148172; PMCID: PMC7144304.
  17. Rosen B, Waitzberg R, Israeli A. Israel's rapid rollout of vaccinations for COVID-19. Isr J Health Policy Res. 2021 Jan 26;10(1):6. doi: 10.1186/s13584-021-00440-6. PMID: 33499905; PMCID: PMC7835664.
  18. MacDonald NE, Smith J, Appleton M. Risk perception, risk management and safety assessment: what can governments do to increase public confidence in their vaccine system? Biologicals. 2012 Sep;40(5):384-8. doi: 10.1016/j.biologicals.2011.08.001. Epub 2011 Oct 10. PMID: 21993306.
  19. André FE. The future of vaccines, immunisation concepts and practice. Vaccine. 2001 Mar 21;19(17-19):2206-9. doi: 10.1016/s0264-410x(00)00546-6. PMID: 11257334.
  20. De Jong MC, Bouma A. Herd immunity after vaccination: how to quantify it and how to use it to halt disease. Vaccine. 2001 Mar 21;19(17-19):2722-8. doi: 10.1016/s0264-410x(00)00509-0. PMID: 11257415.
  21. Carlsen B, Glenton C. The swine flu vaccine, public attitudes, and researcher interpretations: a systematic review of qualitative research. BMC Health Serv Res. 2016 Jun 24;16:203. doi: 10.1186/s12913-016-1466-7. PMID: 27338141; PMCID: PMC4919843.
  22. Li YD, Chi WY, Su JH, Ferrall L, Hung CF, Wu TC. Coronavirus vaccine development: from SARS and MERS to COVID-19. J Biomed Sci. 2020 Dec 20;27(1):104. doi: 10.1186/s12929-020-00695-2. PMID: 33341119; PMCID: PMC7749790.
  23. Ong E, Wong MU, Huffman A, He Y. COVID-19 coronavirus vaccine design using reverse vaccinology and machine learning. bioRxiv [Preprint]. 2020 Mar 21:2020.03.20.000141. doi: 10.1101/2020.03.20.000141. Update in: Front Immunol. 2020 Jul 03;11:1581. PMID: 32511333; PMCID: PMC7239068.
  24. Moore S, Hill EM, Tildesley MJ, Dyson L, Keeling MJ. Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study. Lancet Infect Dis. 2021 Jun;21(6):793-802. doi: 10.1016/S1473-3099(21)00143-2. Epub 2021 Mar 18. PMID: 33743847; PMCID: PMC7972312.
  25. Randolph HE, Barreiro LB. Herd Immunity: Understanding COVID-19. Immunity. 2020 May 19;52(5):737-741. doi: 10.1016/j.immuni.2020.04.012. PMID: 32433946; PMCID: PMC7236739.
  26. Oria PA, Matini W, Nelligan I, Emukule G, Scherzer M, Oyier B, Ochieng HN, Hooper L, Kanyuga A, Muthoka P, Morales KF, Nzioka C, Breiman RF, Katz MA. Are Kenyan healthcare workers willing to receive the pandemic influenza vaccine? Results from a cross-sectional survey of healthcare workers in Kenya about knowledge, attitudes and practices concerning infection with and vaccination against 2009 pandemic influenza A (H1N1), 2010. Vaccine. 2011 Apr 27;29(19):3617-22. doi: 10.1016/j.vaccine.2011.01.063. Epub 2011 Feb 4. PMID: 21296117.
  27. Fatiregun AA, Adeyemo AA, Olowookere SA. Willingness to receive pandemic influenza A (H1N1) vaccine among doctors and nurses in public health facilities in Ibadan, Nigeria. Vaccine. 2012 Mar 16;30(13):2315-9. doi: 10.1016/j.vaccine.2012.01.060. Epub 2012 Jan 31. PMID: 22306857.
  28. Ahmed GY, Balkhy HH, Bafaqeer S, Al-Jasir B, Althaqafi A. Acceptance and Adverse Effects of H1N1 Vaccinations Among a Cohort of National Guard Health Care Workers during the 2009 Hajj Season. BMC Res Notes. 2011 Mar 13;4:61. doi: 10.1186/1756-0500-4-61. PMID: 21396123; PMCID: PMC3063226.
  29. Lau JT, Yeung NC, Choi KC, Cheng MY, Tsui HY, Griffiths S. Acceptability of A/H1N1 vaccination during pandemic phase of influenza A/H1N1 in Hong Kong: population based cross sectional survey. BMJ. 2009 Oct 27;339:b4164. doi: 10.1136/bmj.b4164. PMID: 19861377; PMCID: PMC2768779.
  30. Schwarzinger M, Flicoteaux R, Cortarenoda S, Obadia Y, Moatti JP. Low acceptability of A/H1N1 pandemic vaccination in French adult population: did public health policy fuel public dissonance? PLoS One. 2010 Apr 16;5(4):e10199. doi: 10.1371/journal.pone.0010199. PMID: 20421908; PMCID: PMC2856629.
  31. Beigi RH, Switzer GE, Meyn LA. Acceptance of a pandemic avian influenza vaccine in pregnancy. J Reprod Med. 2009 Jun;54(6):341-6. PMID: 19639922.
  32. Pugliese-Garcia M, Heyerdahl LW, Mwamba C, Nkwemu S, Chilengi R, Demolis R, Guillermet E, Sharma A. Factors influencing vaccine acceptance and hesitancy in three informal settlements in Lusaka, Zambia. Vaccine. 2018 Sep 5;36(37):5617-5624. doi: 10.1016/j.vaccine.2018.07.042. Epub 2018 Aug 4. PMID: 30087047; PMCID: PMC6143480.
  33. Sarasty O, Carpio CE, Hudson D, Guerrero-Ochoa PA, Borja I. The demand for a COVID-19 vaccine in Ecuador. Vaccine. 2020 Dec 3;38(51):8090-8098. doi: 10.1016/j.vaccine.2020.11.013. Epub 2020 Nov 6. PMID: 33187765; PMCID: PMC7832521.
  34. Wang J, Jing R, Lai X, Zhang H, Lyu Y, Knoll MD, Fang H. Acceptance of COVID-19 Vaccination during the COVID-19 Pandemic in China. Vaccines (Basel). 2020 Aug 27;8(3):482. doi: 10.3390/vaccines8030482. PMID: 32867224; PMCID: PMC7565574.
  35. Ward JK, Alleaume C, Peretti-Watel P; COCONEL Group. The French public's attitudes to a future COVID-19 vaccine: The politicization of a public health issue. Soc Sci Med. 2020 Nov;265:113414. doi: 10.1016/j.socscimed.2020.113414. Epub 2020 Oct 6. PMID: 33038683; PMCID: PMC7537647.
  36. Ward JK, Alleaume C, Peretti-Watel P; COCONEL Group. The French public's attitudes to a future COVID-19 vaccine: The politicization of a public health issue. Soc Sci Med. 2020 Nov;265:113414. doi: 10.1016/j.socscimed.2020.113414. Epub 2020 Oct 6. PMID: 33038683; PMCID: PMC7537647.
  37. Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, Kimball S, El-Mohandes A. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021 Feb;27(2):225-228. doi: 10.1038/s41591-020-1124-9. Epub 2020 Oct 20. Erratum in: Nat Med. 2021 Jan 11;: PMID: 33082575; PMCID: PMC7573523.
  38. Al-Mohaithef M, Padhi BK. Determinants of COVID-19 Vaccine Acceptance in Saudi Arabia: A Web-Based National Survey. J Multidiscip Healthc. 2020 Nov 20;13:1657-1663. doi: 10.2147/JMDH.S276771. PMID: 33262600; PMCID: PMC7686470.
  39. Edwards B, Biddle N, Gray M, Sollis K. COVID-19 vaccine hesitancy and resistance: Correlates in a nationally representative longitudinal survey of the Australian population. PLoS One. 2021 Mar 24;16(3):e0248892. doi: 10.1371/journal.pone.0248892. PMID: 33760836; PMCID: PMC7990228.
  40. Fisher KA, Bloomstone SJ, Walder J, Crawford S, Fouayzi H, Mazor KM. Attitudes Toward a Potential SARS-CoV-2 Vaccine : A Survey of U.S. Adults. Ann Intern Med. 2020 Dec 15;173(12):964-973. doi: 10.7326/M20-3569. Epub 2020 Sep 4. PMID: 32886525; PMCID: PMC7505019.
  41. Ditekemena JD, Nkamba DM, Mutwadi A, Mavoko HM, Siewe Fodjo JN, Luhata C, Obimpeh M, Van Hees S, Nachega JB, Colebunders R. COVID-19 Vaccine Acceptance in the Democratic Republic of Congo: A Cross-Sectional Survey. Vaccines (Basel). 2021 Feb 14;9(2):153. doi: 10.3390/vaccines9020153. PMID: 33672938; PMCID: PMC7917589.
  42. Saied SM, Saied EM, Kabbash IA, Abdo SAE. Vaccine hesitancy: Beliefs and barriers associated with COVID-19 vaccination among Egyptian medical students. J Med Virol. 2021 Jul;93(7):4280-4291. doi: 10.1002/jmv.26910. Epub 2021 Mar 25. PMID: 33644891; PMCID: PMC8013865.
  43. Agyekum MW, Afrifa-Anane GF, Kyei-Arthur F, Addo B. Acceptability of COVID-19 Vaccination among Health Care Workers in Ghana. Advances in Public Health. 2021;2021:9998176. doi: 10.1155/2021/9998176
  44. El-Elimat T, AbuAlSamen MM, Almomani BA, Al-Sawalha NA, Alali FQ. Acceptance and attitudes toward COVID-19 vaccines: A cross-sectional study from Jordan. PLoS One. 2021 Apr 23;16(4):e0250555. doi: 10.1371/journal.pone.0250555. PMID: 33891660; PMCID: PMC8064595.
  45. Kanyike AM, Olum R, Kajjimu J, Ojilong D, Akech GM, Nassozi DR, Agira D, Wamala NK, Asiimwe A, Matovu D, Nakimuli AB, Lyavala M, Kulwenza P, Kiwumulo J, Bongomin F. Acceptance of the coronavirus disease-2019 vaccine among medical students in Uganda. Trop Med Health. 2021 May 13;49(1):37. doi: 10.1186/s41182-021-00331-1. PMID: 33985592; PMCID: PMC8116637.
  46. Al-Qerem WA, Jarab AS. COVID-19 Vaccination Acceptance and Its Associated Factors Among a Middle Eastern Population. Front Public Health. 2021 Feb 10;9:632914. doi: 10.3389/fpubh.2021.632914. PMID: 33643995; PMCID: PMC7902782.
  47. Kabamba Nzaji M, Kabamba Ngombe L, Ngoie Mwamba G, Banza Ndala DB, Mbidi Miema J, Luhata Lungoyo C, Lora Mwimba B, Cikomola Mwana Bene A, Mukamba Musenga E. Acceptability of Vaccination Against COVID-19 Among Healthcare Workers in the Democratic Republic of the Congo. Pragmat Obs Res. 2020 Oct 29;11:103-109. doi: 10.2147/POR.S271096. PMID: 33154695; PMCID: PMC7605960.
  48. Fares S, Elmnyer MM, Mohamed SS, Elsayed R. COVID-19 Vaccination Perception and Attitude among Healthcare Workers in Egypt. J Prim Care Community Health. 2021 Jan-Dec;12:21501327211013303. doi: 10.1177/21501327211013303. PMID: 33913365; PMCID: PMC8111272.
  49. Dinga JN, Sinda LK, Titanji VPK. Assessment of Vaccine Hesitancy to a COVID-19 Vaccine in Cameroonian Adults and Its Global Implication. Vaccines (Basel). 2021 Feb 19;9(2):175. doi: 10.3390/vaccines9020175. PMID: 33669659; PMCID: PMC7922050.
  50. Seale H, Kaur R, Wang Q, Yang P, Zhang Y, Wang X, Li X, Zhang H, Zhang Z, MacIntyre CR. Acceptance of a vaccine against pandemic influenza A (H1N1) virus amongst healthcare workers in Beijing, China. Vaccine. 2011 Feb 11;29(8):1605-10. doi: 10.1016/j.vaccine.2010.12.077. Epub 2011 Jan 4. PMID: 21211593.
  51. Torun SD, Torun F. Vaccination against pandemic influenza A/H1N1 among healthcare workers and reasons for refusing vaccination in Istanbul in last pandemic alert phase. Vaccine. 2010 Aug 9;28(35):5703-10. doi: 10.1016/j.vaccine.2010.06.049. Epub 2010 Jun 30. PMID: 20600497.
  52. Chor JS, Ngai KL, Goggins WB, Wong MC, Wong SY, Lee N, Leung TF, Rainer TH, Griffiths S, Chan PK. Willingness of Hong Kong healthcare workers to accept pre-pandemic influenza vaccination at different WHO alert levels: two questionnaire surveys. BMJ. 2009 Aug 25;339:b3391. doi: 10.1136/bmj.b3391. PMID: 19706937; PMCID: PMC2731837.
  53. Fokoun C. Strategies implemented to address vaccine hesitancy in France: A review article. Hum Vaccin Immunother. 2018 Jul 3;14(7):1580-1590. doi: 10.1080/21645515.2018.1458807. Epub 2018 Jun 14. PMID: 29608390; PMCID: PMC6067858.
  54. Jemielniak D, Krempovych Y. An analysis of AstraZeneca COVID-19 vaccine misinformation and fear mongering on Twitter. Public Health. 2021 Aug 30;200:4-6. doi: 10.1016/j.puhe.2021.08.019. Epub ahead of print. PMID: 34628307; PMCID: PMC8494632.
  55. Carrion-Alvarez D, Tijerina-Salina PX. Fake news in COVID-19: A perspective. Health Promot Perspect. 2020 Nov 7;10(4):290-291. doi: 10.34172/hpp.2020.44. PMID: 33312921; PMCID: PMC7722992.
  56. Burki T. The online anti-vaccine movement in the age of COVID-19. Lancet Digit Health. 2020 Oct;2(10):e504-e505. doi: 10.1016/S2589-7500(20)30227-2. Epub 2020 Sep 22. PMID: 32984795; PMCID: PMC7508526.
  57. Cinelli M, Quattrociocchi W, Galeazzi A, Valensise CM, Brugnoli E, Schmidt AL, Zola P, Zollo F, Scala A. The COVID-19 social media infodemic. Sci Rep. 2020 Oct 6;10(1):16598. doi: 10.1038/s41598-020-73510-5. PMID: 33024152; PMCID: PMC7538912.
  58. de Figueiredo A, Simas C, Karafillakis E, Paterson P, Larson HJ. Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective temporal modelling study. Lancet. 2020 Sep 26;396(10255):898-908. doi: 10.1016/S0140-6736(20)31558-0. Epub 2020 Sep 10. PMID: 32919524; PMCID: PMC7607345.
  59. Li HO, Bailey A, Huynh D, Chan J. YouTube as a source of information on COVID-19: a pandemic of misinformation? BMJ Glob Health. 2020 May;5(5):e002604. doi: 10.1136/bmjgh-2020-002604. PMID: 32409327; PMCID: PMC7228483.
  60. Germani F, Biller-Andorno N. The anti-vaccination infodemic on social media: A behavioral analysis. PLoS One. 2021 Mar 3;16(3):e0247642. doi: 10.1371/journal.pone.0247642. PMID: 33657152; PMCID: PMC7928468.
  61. Wirsiy FS, Nkfusai CN, Ako-Arrey DE, Dongmo EK, Manjong FT, Cumber SN. Acceptability of COVID-19 Vaccine in Africa. Int J MCH AIDS. 2021;10(1):134-138. doi: 10.21106/ijma.482. Epub 2021 Apr 8. PMID: 33868778; PMCID: PMC8039868.
  62. WHO. Report of the SAGE Working Group on Vaccine Hesitancy. Geneva. 2014.
  63. https://bit.ly/3jKhIHw
  64. WHO. Addressing Vaccine Hesitancy. 2016.
  65. https://bit.ly/3CrD9Ez
  66. Williamson L, Glaab H. Addressing vaccine hesitancy requires an ethically consistent health strategy. BMC Med Ethics. 2018 Oct 24;19(1):84. doi: 10.1186/s12910-018-0322-1. PMID: 30355355; PMCID: PMC6201581.
  67. Jarrett C, Wilson R, O'Leary M, Eckersberger E, Larson HJ; SAGE Working Group on Vaccine Hesitancy. Strategies for addressing vaccine hesitancy - A systematic review. Vaccine. 2015 Aug 14;33(34):4180-90. doi: 10.1016/j.vaccine.2015.04.040. Epub 2015 Apr 18. PMID: 25896377.
  68. Sonawane K, Troisi CL, Deshmukh AA. COVID-19 vaccination in the UK: Addressing vaccine hesitancy. Lancet Reg Health Eur. 2021 Feb;1:100016. doi: 10.1016/j.lanepe.2020.100016. Epub 2021 Jan 13. PMID: 34173622; PMCID: PMC7834442.
  69. Leask J, Willaby HW, Kaufman J. The big picture in addressing vaccine hesitancy. Hum Vaccin Immunother. 2014;10(9):2600-2. doi: 10.4161/hv.29725. Epub 2014 Nov 19. PMID: 25483479; PMCID: PMC4975059.
Publish with JBRES — Peer-reviewed, multidisciplinary Open Access with rapid review, DOI, and global visibility.
Double-Blind CrossRef DOI Discoverable
Submit Manuscript Membership